Abstract: A comprehensive aerosol therapy for administration to a patient in need of treatment is provided. More particularly, the aerosol therapy kit provides a seamless conduit for a patient to receive in-office or hospital inhalation treatments and access to drugs and equipment for continuing home use.

Abstract: A composition for the treatment and prophylactic management of bacterial and fungal respiratory infections is provided. The composition may contain a combination of a quaternary ammonium compound and hypertonic saline to be administered to a patient in need thereof.

Abstract: The present invention provides compositions and methods for treating sore throat by reducing inflammation and clearing oral-pharyngeal mucus associated with sore throat comprising hypertonic saline and menthol.

Abstract: Sterile, preservative-free premeasured hypertonic saline solutions may be administered to individuals afflicted with cystic fibrosis to increase mucolciliary clearance and to improve lung function. In particular, a 7% hypertonic saline solution may be administered at least 2 times a day, using a jet and/or vibrating-mesh nebulizer to an individual afflicted with cystic fibrosis.

Abstract: The invention relates to a racemic epinephrine inhalation solution, system, kit, and method for the treatment of croup. In particular, the racemic epinephrine solution is premixed, sterile, premeasured single unit dose of racemic epinephrine for the treatment of croup. More particularly, the racemic inhalation solution is free of antimicrobial preservatives and other preservatives. Additionally, the invention also relates to a comprehensive kit to administer racemic epinephrine aerosol therapy for the treatment of croup. More particularly, the invention relates to an inhalation therapy kit to provide a seamless conduit for a patient to receive in-office or hospital inhalation treatments and access to drugs and equipment for continuing home use.

Abstract: Medical devices and methods are provided for the pulmonary delivery of a drug in heliox gas. One method comprises (a) providing a medical device which comprises an aerosolization means, a conduit means, a gas mask, and a source of heliox gas, the medical device being operable as a closed system to prevent entrainment of ambient air into an inhaled aerosol; (b) providing a drug in a liquid or dry powder form; (c) using the aerosolization means to form an aerosol of particles or droplets dispersed in heliox gas, said particles or droplets comprising the drug and said heliox gas being from said source; and (d) flowing the aerosol through the conduit means and into the gas mask secured over a patient's mouth and nose in a manner for the patient to inhale the aerosol without dilution of the aerosol with ambient air.